- NCIt
- C3708
Loading cancer entity…
Loading cancer entity…
Clinical trials
349 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07614620 | Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast Cancer(HYPNO-AJA2) | recruiting | N/A | 70 | Institut BergoniéOTHER | 1 | Sep 22, 2026 | clinicaltrials |
| NCT01696994 | Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial) | active not recruiting | N/A | 78,216 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2026 |
| clinicaltrials |
| NCT07699640 | Minimally-invasive ICG-guided Retroperitoneal Sentinel Lymph Node Dissection in the Primary Staging of Testicular Cancer Versus Standard of Care(RAISN 2) | not yet recruiting | N/A | 171 | Heinrich-Heine University, DuesseldorfOTHER | 2 | Jul 13, 2026 | clinicaltrials |
| NCT01049230 | Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell Tumors | active not recruiting | N/A | 45 | Massachusetts General HospitalOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT02537548 | Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma | active not recruiting | N/A | 55 | University of Southern CaliforniaOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT07601672 | PRISTINE Trial: PRoton Beam Therapy In Seminoma - Toxicity INvestigation and Evaluation of Outcome(PRISTINE) | not yet recruiting | N/A | 20 | Istituto Clinico HumanitasOTHER | 0 | May 22, 2026 | clinicaltrials |
| NCT07498959 | Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer(TESTIGO) | recruiting | N/A | 160 | Sahlgrenska University HospitalOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07463508 | Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity(TG-BIL) | recruiting | N/A | 20 | University Hospital, Clermont-FerrandOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT05345158 | R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma | recruiting | N/A | 25 | University Health Network, TorontoOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT07199699 | Subxiphoid VATS for Giant Mediastinal Teratoma | not yet recruiting | N/A | 40 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Sep 30, 2025 | clinicaltrials |
| NCT03418844 | Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy(VIVROVAIRE TR) | active not recruiting | N/A | 268 | Centre Francois BaclesseOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT06133543 | Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer(RAISN) | recruiting | N/A | 44 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT04671693 | A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.(PASCA) | active not recruiting | N/A | 500 | Centre Leon BerardOTHER | 1 | Sep 5, 2025 | clinicaltrials |
| NCT05142982 | Radiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced Seminoma | recruiting | N/A | 74 | Tata Memorial CentreOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT05889585 | Morbidity, Long-term Side Effects and Quality of Life in Germ-cell Tumor Long Survivors Treated with High-dose Chemotherapy and Autologous Stem Cell Transplant(HGT-QoL) | recruiting | N/A | 180 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Oct 18, 2024 | clinicaltrials |
| NCT05502224 | Multidisciplinary Approach to Fatigue | recruiting | N/A | 50 | Jules Bordet InstituteOTHER | 1 | Nov 8, 2022 | clinicaltrials |
Data updated 5 days agoSource updated Sep 22, 2026source: clinicaltrials